Eric Easom - 15 May 2023 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Easom
Issuer symbol
ANTX
Transactions as of
15 May 2023
Net transactions value
+$53,770
Form type
4
Filing time
15 May 2023, 20:01:16 UTC
Previous filing
24 Feb 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Purchase $53,770 +10,000 +0.99% $5.38 1,015,766 15 May 2023 See Footnote F1
holding ANTX Common Stock 4,907 15 May 2023 Direct
holding ANTX Common Stock 97,058 15 May 2023 See Footnote F2
holding ANTX Common Stock 97,058 15 May 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
F2 Consists of shares of Common Stock held by the C Easom Irrevocable Trust dated October 8, 2021.
F3 Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.